After identifying and confirming differential expression of sFRP2 in mouse and human metastatic OS, and its clinical relevance for patients with bone sarcomas, our goal was to elucidate the phenotypic effects of sFRP2 on osteosarcoma. This evidence concerns the gene SFRP2 and osteosarcoma.